Ocumetics Technology Corp

Ocumetics Technology Corp

OTC · V · Healthcare / Medical Instruments & Supplies

0.37CAD-0.01 (-2.63%)

Price History

Full chart

Market Stats

Previous Close0.38
Open0.365
Day Range0.365 – 0.38
52-Week Range0.35 – 1.30
Volume34.91K
Market Cap53.32M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.05
Dividend Yield0.00%
Beta0.33
50-Day Avg0.4483
200-Day Avg0.5034

About

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The company was founded in 2012 and is headquartered in Calgary, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Dean E. Burns
  • Employees0
  • Headquarters1250, 639-5th Avenue SW, Calgary, AB, Canada, T2P 0M9, Canada
  • Websitehttps://ocumetics.com

Leadership

  • Dr. Garth T. WebbFounder, Chairman & Chief Scientific Officer
  • Mr. Dean E. BurnsPresident, CEO & Director
  • Mr. Roger M. Jewett C.A., CPACFO & Director · b. 1964
  • Dr. R. Doyle StultingChief Medical Officer

Financials

Income Statement

Currency: CAD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--000000
Operating Income---172.49K-598.19K-2.18M-3.61M-2.43M-4.00M
EBITDA---99.35K-514.68K-2.09M-3.50M-2.29M-3.88M
Net Income---172.49K-598.19K-2.22M-3.64M-3.02M-5.37M
R&D---0555.70K907.43K852.39K1.42M
Interest Expense000026.63K29.30K639.05K1.35M

Balance Sheet

Currency: CAD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets---825.25K1.37M1.04M2.32M1.90M
Total Liabilities---1.10M536.45K945.33K4.26M5.85M
Total Equity----270.50K837.40K91.10K-1.94M-3.94M
Cash---83.90K602.09K235.83K195.19K464.04K
Net Debt-----85.81K3.76M4.84M

Cash Flow

Currency: CAD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-47.76K1.01K-817-89.13K-1.62M-2.05M-2.43M-3.37M
Investing Cash Flow-214.92K-214.92K-214.92K-214.92K----
Financing Cash Flow387.11K387.11K387.11K387.11K444.35K1.82M3.85M2.38M
Capital Expenditure000124.50K66.82K142.17K84.86K126.08K
Free Cash Flow---817-213.63K-1.69M-2.19M-2.51M-3.49M
FCF to OCF--100.00%239.68%104.13%106.95%103.49%103.75%

Earnings

Report DateNov 24, 2026
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap53.32M
Enterprise Value63.36M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book41.07
EPS-0.05
Book Value-0.033
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-4.23M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-1122.68%
Return on Assets-295.42%
Shares Outstanding130.04M
Shares Float82.22M
Beta0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%